China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

SHA:600062 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,218	2,851	3,462	2,630	2,834	2,410
Trading Asset Securities	200.64	-	-	200.49	803.58	851.95
Cash & Short-Term Investments	2,419	2,851	3,462	2,831	3,638	3,262
Cash Growth	-10.60%	-17.65%	22.29%	-22.18%	11.51%	20.73%
Accounts Receivable	2,905	2,599	2,633	2,211	1,978	2,086
Other Receivables	33.86	209.04	1,363	468.98	66.14	50.5
Receivables	2,939	2,808	3,997	2,680	2,044	2,137
Inventory	1,640	1,594	1,688	1,900	1,665	1,289
Prepaid Expenses	-	-	-	-	0.59	-
Other Current Assets	346.6	224.59	235.49	227.89	174.55	112.22
Total Current Assets	7,344	7,477	9,382	7,639	7,523	6,800
Property, Plant & Equipment	4,349	4,238	4,046	3,571	2,957	2,673
Long-Term Investments	1,100	1,048	1,016	350.29	303.43	370.08
Goodwill	1,107	878.49	907.9	934.96	788.19	796.41
Other Intangible Assets	1,761	1,749	1,768	1,648	1,193	1,094
Long-Term Accounts Receivable	22.36	2.37	-	-	-	-
Long-Term Deferred Tax Assets	140.45	135.8	140.58	127.19	73.77	52.22
Long-Term Deferred Charges	681.67	744.92	813	792.3	723.66	569.38
Other Long-Term Assets	508.41	412.4	129.8	103.27	114.6	60.72
Total Assets	17,014	16,686	18,203	15,165	13,676	12,416
Accounts Payable	680.5	835.81	740.49	750.39	847.4	848.05
Accrued Expenses	455.75	2,296	1,691	1,496	1,283	1,149
Short-Term Debt	9.55	89.05	59.47	36.95	4.75	-
Current Portion of Long-Term Debt	-	12	200.25	0.27	-	-
Current Portion of Leases	-	11.31	22.49	19.46	17.84	-
Current Income Taxes Payable	162.72	43.84	65.72	77.78	59.62	58.92
Current Unearned Revenue	154.8	174.88	293.43	194.21	201.35	146.24
Other Current Liabilities	1,801	539.73	1,706	507.17	317.31	467.45
Total Current Liabilities	3,264	4,003	4,779	3,082	2,731	2,670
Long-Term Debt	1,127	1,090	-	200	-	-
Long-Term Leases	28.99	22.1	29.95	32.93	35.43	-
Long-Term Unearned Revenue	146.23	160.67	182.31	199.61	153.92	101.02
Pension & Post-Retirement Benefits	166.21	169.64	147.55	144.18	157.75	150.43
Long-Term Deferred Tax Liabilities	101.64	123.6	158.59	176.17	120.35	103.62
Other Long-Term Liabilities	18.24	5.67	5.67	5.06	1.11	14.4
Total Liabilities	4,853	5,574	5,303	3,840	3,199	3,040
Common Stock	1,039	1,039	1,040	1,043	1,043	1,043
Additional Paid-In Capital	203.39	193.45	837.55	275.22	149.39	149.39
Retained Earnings	10,129	9,269	10,460	9,415	8,718	8,102
Treasury Stock	-37.95	-74.36	-125.56	-175.68	-	-
Comprehensive Income & Other	-15.11	-19.3	1.32	-1.43	-5.17	-0.28
Total Common Equity	11,319	10,408	12,213	10,556	9,905	9,294
Minority Interest	842.22	703.89	685.95	768.46	571.06	82.88
Shareholders' Equity	12,161	11,112	12,899	11,325	10,477	9,377
Total Liabilities & Equity	17,014	16,686	18,203	15,165	13,676	12,416
Total Debt	1,166	1,224	312.16	289.61	58.02	-
Net Cash (Debt)	1,253	1,626	3,150	2,541	3,580	3,262
Net Cash Growth	-37.16%	-48.36%	23.94%	-29.00%	9.73%	23.67%
Net Cash Per Share	1.21	1.58	3.07	2.45	3.43	3.13
Filing Date Shares Outstanding	1,038	1,027	1,021	1,040	1,043	1,043
Total Common Shares Outstanding	1,038	1,027	1,021	1,040	1,043	1,043
Working Capital	4,080	3,474	4,602	4,556	4,792	4,130
Book Value Per Share	10.90	10.13	11.96	10.15	9.49	8.91
Tangible Book Value	8,451	7,780	9,537	7,973	7,925	7,403
Tangible Book Value Per Share	8.14	7.57	9.34	7.67	7.60	7.10
Buildings	-	3,452	3,162	2,579	2,314	2,171
Machinery	-	4,358	4,000	3,306	2,758	2,578
Construction In Progress	-	455.14	570.38	439.72	272.81	281.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.